Cisplatin resistance and regulation of DNA repair in cAMP-dependent protein kinase mutants

Cell Growth and Differentiation

Volumn 7, Issue 8, 1996, Pages 1105-1112

  Liu, Bingren ^a   Cvijic, Mary Ellen ^a   Jetzt, Amanda ^a   Chin, Khew Voon ^a,b  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CISPLATIN; CYCLIC AMP; MELPHALAN; PHOSPHODIESTERASE; PROTEIN KINASE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CHO CELL; DNA DAMAGE; DNA REPAIR; ENZYME ACTIVITY; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN CELL; PLASMID; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ADRENAL GLANDS; ANIMALS; BIOLOGICAL ASSAY; BLEOMYCIN; CELLS, CULTURED; CHO CELLS; CISPLATIN; CRICETINAE; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DNA DAMAGE; DNA REPAIR; DRUG RESISTANCE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GENES, REPORTER; GENETIC TECHNIQUES; MELPHALAN; METHOTREXATE; MICE; MUTATION; ULTRAVIOLET RAYS;

CRICETINAE; CRICETULUS GRISEUS;

EID: 0029842888     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Boynton, A. L., and Whitfield, J. F. The role of cyclic AMP in cell proliferation: a critical assessment of the evidence. Adv. Cyclic Nucleotide Res., 15: 193-294, 1983.
2. Cho-Chung, Y. S. Role of cyclic AMP receptor proteins in growth, differentiation, and suppression of malignancy: new approaches to therapy. Cancer Res., 50: 7093-7100, 1990.
3. Francis, S. H., and Corbin, J. D. Structure and function of cyclic nucleotide-dependent protein kinases. Annu. Rev. Physiol., 56: 237-272, 1994.
4. Lalli, E., and Sassone-Corsi, P. Signal transduction and gene regulation: the nuclear response to cAMP. J. Biol. Chem., 269: 17359-17362, 1994.
5. Daniel, V., Litwack, G., and Tomkins, G. M. Induction of cytolysis of cultured lymphoma cells by adenosine 3′:5′-cyclic monophosphate and the isolation of resistant variants. Proc. Natl. Acad. Sci. USA, 70: 76-79, 1973.
6. Insel, P. A., Bourne, H. R., Coffino, P., and Tornkins, G. M. Cyclic AMP-dependent protein kinase: pivotal role in regulation of enzyme induction and growth. Science (Washington DC), 190: 896-898, 1975.
7. Gottesman, M. M., and Fleischmann, R. D. The role of cAMP in regulating tumor cell growth. Cancer Surv., 5: 291-308, 1986.
8. Gottesman, M. M. Genetic approaches to cyclic AMP effects in cultured mammalian cells. Cell, 22: 329-330, 1980.
9. Gottesman, M. M., LeCam, A., Bukowski, M., and Pastan, I. Isolation of multiple classes of mutants of CHO cells resistant to cyclic AMP. Somat. Cell Genet., 6: 45-61, 1980.
10. Evain, D., Gottesman, M. M., Pastan, I., and Andersen, W. B. A mutation affecting the catalytic subunit of cyclic AMP-dependent protein kinase in CHO cells. J. Biol. Chem., 254: 6931-6937, 1979.
11. Singh, T. J., Roth, C., Gottesman, M. M., and Pastan, I. H. Characterization of cyclic AMP-resistant Chinese hamster ovary cell mutants lacking type I protein kinase. J. Biol. Chem., 256: 926-932, 1981.
12. Singh, T. J., Hochman, J., Verna, R., Chapman, M., Abraham, I., Pastan, I. H., and Gottesman, M. M. Characterization of a cyclic AMP- resistant Chinese hamster ovary cell mutant containing both wild-type and mutant species of type I regulatory subunit of cyclic AMP-dependent protein kinase. J. Biol. Chem., 260: 13927-13933, 1985.
13. Rae, P. A., Gutmann, N. S., Tsao, J., and Schimmer, B. P. Mutations in cyclic AMP-dependent protein kinase and corticotropin (ACTH)-sensitive adenylate cyclase affect adrenal steroidogenesis. Proc. Natl. Acad. Sci. USA, 76: 1896-1900, 1979.
14. Chin, K-V., Pastan, I., and Gottesman, M. M. Function and regulation of the human multidrug resistance gene. Adv. Cancer Res., 60: 157-180, 1993.
15. Gottesman, M. M., and Pastan, I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem., 62: 385-427, 1993.
16. Abraham, I., Hunter, R. J., Sampson, K. E., Smith, S., Gottesman, M. M., and Mayo, J. K. Cyclic AMP-dependent protein kinase regulates sensitivity of cells to multiple drugs. Mol. Cell. Biol., 7: 3098-3106, 1987.
17. Abraham, I., Chin, K-V., Gottesman, M. M., Mayo, J., and Sampson, K. E. Transfection of a mutant regulatory subunit gene of cAMP-dependent protein kinase causes increased drug sensitivity and decreased expression of P-glycoprotein. Exp. Cell Res., 189: 133-141, 1990.
18. Chin, K-V., Chauhan, S. S., Abraham, I., Sampson, K. E., Krolczyk, A. J., Wong, M., Schimmer, B., Pastan, I., and Gottesman, M. M. Reduced expression of the multidrug-resistant gene in cAMP-dependent protein kinase mutant cell lines. J. Cell. Physiol., 152: 87-94, 1992.
19. Kim, S., Park, J., Chung, B., Kang, C., and Hidaka, H. Inhibition of MDR1 gene expression by H-87, a selective inhibitor of cAMP-dependent protein kinase. Cancer Lett., 74: 37-41, 1993
20. m cAMP- phosphodiesterase gene. J. Biol. Chem., 265: 5840-5846, 1990.
21. Howard, P., Day, K. H., Kim, K. E., Richardson, J., Thomas, J., Abraham, I., Fleischmann, R. D., Gottesman, M. M., and Maurer, R. A. Decreased catalytic subunit mRNA levels and altered catalytic subunit mRNA structure in a cAMP-resistant Chinese hamster ovary cell line. J. Biol. Chem., 266: 10189-10195.
22. Payne, A., and Chu, G. Xeroderma pigmentosum group E binding factor recognizes a broad spectrum of DNA damage. Mutation Res., 310: 89-102, 1994.
23. Chu, G., and Chang, E. Xeroderma pigmentosum group E cells lack a nuclear factor that binds to damaged DMA. Science (Washington DC), 242: 564-567, 1988.
24. Chu, G., and Chang, E. Cisplatin resistant cells express increased levels of a factor that recognizes damaged DMA. Proc. Natl. Acad. Sci. USA, 87: 3324-3327, 1990.
25. Sheibani, N., Jennerwein, M. M., and Eastman, A. DNA repair in cells sensitive and resistant to cis-diamminedichloroplatinum(II): host cell reactivation of damaged plasmid DNA. Biochemistry, 28: 3120-3124, 1989.
26. Nordeen, S. K. Luciferase reporter gene vectors for analysis of promoters and enhancers. BioTechniques, 6: 454-457, 1988.
27. Quitschke, W. W., Lin, Z., DePonti-Zilli, L., and Paterson, B. M. The β actin promoter: high levels of transcription depend upon a CCAAT binding factor. J. Biol. Chem., 264: 9539-9546, 1989.
28. Ariza, R. R., Keyse, S. M., Moggs, J. G., and Wood, R. D. Reversible protein phosphorylation modulates nucleotide excision repair of damaged DNA by human cell extracts. Nucleic Acid Res., 24: 433-440, 1996.
29. Hwang, B. J., and Chu, G. Purification and characterization of a human protein that binds to damaged DNA. Biochemistry, 32: 1657-1666, 1993.
30. Dabholkar, M., Bostick-Bruton, F., Weber, C., Bohr, V., Egwuagu, C., and Reed, E. ERCC1 and ERCC2 expression in malignant tissues from ovarian cancer patients. J. Natl. Cancer Inst, 84: 1512-1517, 1992.
31. Pil, P., and Lippard, S. Specific binding of chromosomal protein HMG1 to DNA damaged by the anticancer drug cisplatin. Science (Washington DC), 256: 234-237, 1992.
32. Hughes, E., Engelsberg, B., and Billings, P. Purification of nuclear proteins that bind to cisplatin-damaged DNA. J. Biol. Chem., 267: 13520- 13527, 1992.
33. North, P. S., Davies, S. L., Ciardiello, F., Damiano, V., Bianco, C., Pepe, S., Bianco, A. R., Harris, A. L., Hickson, I. D., and Tortora, G. Overexpression of the Rla subunit of protein kinase A confers hypersensitivity to topoisomerase (I inhibitors and 8-chloro-cyclic adenosine 3′,5′- monophosphate in Chinese hamster ovary cells. Cancer Res., 54: 4123- 4128, 1994.
34. Mann, S. C., Andrews, P. A., and Howell, S. B. Modulation of cis-diamminedichloroplatinum (II) accumulation and sensitivity by forskolin and 3-isobutyl-methyl-xanthine in sensitive and resistant human ovarian carcinoma cells. Int. J. Cancer, 48: 866-872, 1991.
35. Coghlan, V. M., Perrino, B. A., Howard, M., Langeberg, L. K., Hicks, J. B., Gallatin, W. M., and Scott, J. D. Association of protein kinase A and protein phosphatase 2B with a common anchoring protein. Science (Washington DC), 267: 108-111, 1995.
36. Rauth, A. M. Evidence for dark-reactivation of ultraviolet light damage in mouse L cells. Radiat. Res., 31: 121-138, 1967.
37. Walker, I. G., and Reid, B. D. Caffeine potentiation of the lethal action of alkylating agents on L-cells. Mutat. Res., 12: 101-104, 1971.
38. 2 arrest. Radiat. Res., 76: 292-307, 1978.
39. 2 arrest by caffeine. Radiat. Res., 129: 224-227, 1992.
40. Musk, S. R. R. Reduction of radiation-induced cell cycle blocks by caffeine does not necessarily lead to increased cell killing. Int. J. Radiat. Biol., 57: 1105-1112, 1990.
41. Teicher, B. A., Holden, S. A., Herman, T. S., Epelbaum, R., Pardee, A. B., and Dezube, B. Efficacy of pentoxifylline as a modulator of alkylating agent activity in vitro and in vivo. Anticancer Res., 11: 1555-1560, 1991.
42. Schlegel, R., and Pardee, A. B. Caffeine-induced uncoupling of mitosis from completion of DNA replication in mammalian cells. Science (Washington DC), 232: 1264-1266, 1986.
43. Murnane, J. P., Byfield, J. E., Chen, C-T., and Wang, C. H. The structure of methylated xanthines in relation to their effects on DNA synthesis and cell lethality in nitrogen mustard treated cells. Biophys. J., 35: 665-676, 1981.
44. Beavo, J. A., and Reifsnyder, D. H. Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. Trends Pharmacol. Sci., 11: 150-155, 1990.
45. Selby, C. P., and Sancar, A. Molecular mechanisms of DMA repair inhibition by caffeine. Proc. Natl. Acad. Sci. USA, 87: 3522-352, 1990.
46. Lau, C. C., and Pardee, A. B. Mechanism by which caffeine potentiates lethality of nitrogen mustard. Proc. Natl. Acad. Sci. USA, 79: 2942- 2946, 1982.
47. Murata, T. H., Hibasami, H., Maekawa, S., Tagawa, T., and Nakashima, K. Preferential binding of cisplatin to mitochondrial DNA and suppression of ATP generation in human malignant melanoma cells. Biochem. Int., 20: 949-955, 1990.
48. Singh, G., and Maniccia-Bozzo, E. Evidence for lack of mitochondrial DNA repair following cis-dichlorodiammineplatinum treatment. Cancer Chemother. Pharmacol., 26: 97-100, 1990.
49. Olivero, O. A., Semino, C., Kassim, A., Lopez-Larraza, D. M., and Poirier, M. C. Preferential binding of cisplatin to mitochondrial DNA of Chinese hamster ovary cells. Mutat. Res., 346: 221-230, 1995.
50. LeDoux, S. P., Wilson, G. L., Beecham, E. J., Stevnsner, T., Wassermann, K., and Bohr, V. A. Repair of mitochondrial DNA after various types of DNA damage in Chinese hamster ovary cells. Carcinogenesis (Lond.), 13: 1967-1973, 1992.
51. Chin, K-V., Ueda, K., Pastan, I., and Gottesman, M. M. Ras and p53 modulate the activity of the promoter of the human multidrug resistance (MDR1) gene. Science (Washington DC), 255: 459-462, 1992.
52. Mossmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxic assays. J. Immunol. Methods, 65: 55-63, 1983.
53. Schreiber, E., Matthias, P., Muller, M. M., and Schaffner, W. Rapid detection of octamer binding proteins with "mini-extracts," prepared from a small number of cells. Nucleic Acids Res., 17: 6419, 1989.
54. Wigler, M., Sweet, R., Sim, G. K., Wold, B., Pellicer, A., Lacy, E., Maniatis, T., Silverstein, S., and Axel, R. Transformation of mammalian cells with genes from prokaryotes and eukaryotes. Cell, 16: 777-786, 1979.
55. Sleigh, M. A. A nonchromatographic assay for expression of the chloramphenicol acetyltransferase gene in eukaryotic cells. Anal. Biochem., 156: 251-256, 1986.